Philippines Department of Justice recommends charges against six Sanofi officials
pharmafile | March 1, 2019 | News story | Medical Communications | Philippines, Sanofi, dengue, dengvaxia, vaccines
The Philippine Justice Ministry has said it has found probably cause to charge officials working for French drugmaker Sanofi over the death and injury of hundreds of children and adults relating to a dangerous dengue vaccine.
One hundred and eighteen people, including 115 children and 33 adults, died after receiving Sanofi’s dengue vaccine, Dengvaxia, in 2016 after the Philippines became one of the first countries to use the vaccine in a mass immunisation programme.
The programme was suspended in 2017 after Sanofi announced that the vaccine could make cases of dengue worse in some cases in which patients had had no previous exposure.
The Philippines Department of Justice said in a statement on Friday that it would recommend charges be filed in court for reckless imprudence resulting in homicide, due to what it said were procedural lapses in the implementation of a dengue immunization program in 2016.
The government body recommended charges be filed against six Sanofi officials and 14 current and former Philippines health officials.
Louis Goss
Related Content
Merck plans to conduct trials for HPV vaccines
Merck, known as MSD outside of the US and Canada, has announced that it is …
Sanofi shares phase 2b results for dermatitis treatment
Sanofi has shared positive results from part 2 of the investigational phase 2b STREAM-AD study …
Measles: the UK’s next epidemic?
Recently, the UK has seen a rapid increase in the number of cases of measles, …